Rituximab Plus Chlorambucil As First-Line Treatment for Chronic Lymphocytic Leukemia: Final Analysis of an Open-Label Phase II Study

PURPOSE: Most patients with chronic lymphocytic leukemia (CLL) are elderly and/or have comorbidities that may make them ineligible for fludarabine-based treatment. For this population, chlorambucil monotherapy is an appropriate therapeutic option; however, response rates with chlorambucil are low, a...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Clin Oncol
Hoofdauteurs: Hillmen, Peter, Gribben, John G., Follows, George A., Milligan, Donald, Sayala, Hazem A., Moreton, Paul, Oscier, David G., Dearden, Claire E., Kennedy, Daniel B., Pettitt, Andrew R., Nathwani, Amit, Varghese, Abraham, Cohen, Dena, Rawstron, Andy, Oertel, Stephan, Pocock, Christopher F.E.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Clinical Oncology 2014
Onderwerpen:
ORIGINAL REPORTS
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4876343/
https://ncbi.nlm.nih.gov/pubmed/24638012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.49.6547
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items